Logo

Helmholtz Center for Infection Research: Josef Penninger, Dirk Heinz

Jun 28, 2023

Josef Penninger has been appointed as scientific director of the Helmholtz Center for Infection Research (HZI) in Braunschweig, Germany, taking over from Dirk Heinz. In addition, he has been appointed as professor for precision medicine at the Medical University of Vienna. Penninger joins HZI from the University of British Columbia, where he led the Life Science Institute. He holds an MD from the Medical University of Innsbruck in Austria.

Breaking News
The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.